|
|
|
Wednesday, February 2, 2011
|
11:15 am -
12:00 pm
|
- Discuss approaches to translate scientific evidence into integrated clinical practice guidelines for CVD risk reduction
- Identify the opportunities and the difficulties in coordinating clinical recommendations across related topics
- Consider how to minimize inconsistencies in recommendations in correlated guidelines for hypertension (HTN), dyslipidemia, obesity and diabetes
- Provide best practice guidelines from Kaiser Permanente’s cardiovascular risk reduction program, which includes the ALL initiative and PHASE program
- Learn the NHLBI guidelines development process for hypertension, dyslipidemia and obesity, as well as integrated cardiovascular prevention guidelines
|
|
|
Marc Jaffe, MD
Clinical Leader, Kaiser Northern California Cardiovascular Risk Reduction Program
Endocrinology and Internal Medicine
Kaiser South San Francisco Medical Center
|
|
|
Denise Simons-Morton, MD, MPH, PhD
Director, Division for the Application of Research Discoveries
National Heart, Lung, and Blood Institute
 View Biography
|
|
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page